Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.

[1]  A. Santoro,et al.  EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide , 2022, Bone Marrow Transplantation.

[2]  Gyeong-Won Lee,et al.  Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancer. , 2022, Cancer biomarkers : section A of Disease markers.

[3]  H. Nakamae.  Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide , 2022, International Journal of Hematology.

[4]  Gyeong-Won Lee,et al.  The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma , 2022, BMC Cancer.

[5]  P. Pedrazzoli,et al.  Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 , 2022, Bone Marrow Transplantation.

[6]  María Teresa Solano,et al.  PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT. , 2022, Transplantation and cellular therapy.

[7]  T. Luft,et al.  Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation , 2022, Intensive Care Medicine.

[8]  L. Bullinger,et al.  EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study , 2022, Frontiers in Immunology.

[9]  K. Simon,et al.  Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study , 2021, Journal of clinical medicine.

[10]  J. Torres-Macho,et al.  Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019 , 2021, Frontiers in Medicine.

[11]  A. Sureda,et al.  Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation. , 2021, Blood advances.

[12]  M. Perales,et al.  Modified-EASIX predicts severe cytokine release syndrome and neurotoxicity after Chimeric Antigen Receptor (CAR) T cells. , 2021, Blood advances.

[13]  Michael L. Wang,et al.  CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. , 2021, Blood advances.

[14]  T. Luft,et al.  Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation , 2021, Bone Marrow Transplantation.

[15]  A. Hajifathali,et al.  Pre-and Post-Transplant Serum Lactate Dehydrogenase Levels as a Predictive Marker for Patient Survival and Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients. , 2021, Reports of biochemistry & molecular biology.

[16]  T. Luft,et al.  EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients , 2021, Frontiers in Immunology.

[17]  B. Bruno,et al.  Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role? , 2021, Frontiers in Immunology.

[18]  G. Gutiérrez-García,et al.  High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation. , 2021, Transplantation and cellular therapy.

[19]  L. Bullinger,et al.  Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication , 2021, Bone Marrow Transplantation.

[20]  S. Montoto,et al.  How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT. , 2020, Blood advances.

[21]  Kihyun Kim,et al.  Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma , 2020, BMC Cancer.

[22]  Enrico Longato,et al.  A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models , 2020, J. Biomed. Informatics.

[23]  N. Chao,et al.  Endothelial cell function and endothelial‐related disorders following haematopoietic cell transplantation , 2020, British journal of haematology.

[24]  María Teresa Solano,et al.  Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis , 2020, Bone Marrow Transplantation.

[25]  R. Champlin,et al.  Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation. , 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  L. Bullinger,et al.  Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel , 2020, Haematologica.

[27]  M. Perales,et al.  Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation , 2019, Blood advances.

[28]  A. Jauch,et al.  EASIX for prediction of survival in lower-risk myelodysplastic syndromes , 2019, Blood Cancer Journal.

[29]  M. Sorror,et al.  EASIX and mortality after allogeneic stem cell transplantation , 2019, Bone Marrow Transplantation.

[30]  M. Robin,et al.  Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions. , 2019, Blood advances.

[31]  N. Young,et al.  Aging and Hematopoiesis. , 2019, Clinics in geriatric medicine.

[32]  A. Nagler,et al.  External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation. , 2019, Blood advances.

[33]  M. Díaz-Ricart,et al.  Endothelial Dysfunction in Hematopoietic Cell Transplantation , 2019, Clinical hematology international.

[34]  R. Storb,et al.  EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. , 2017, The Lancet. Haematology.

[35]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[36]  A. Schulz,et al.  Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial , 2012, The Lancet.

[37]  C. Bal,et al.  The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients. , 2011, Clinical nephrology.

[38]  M. Díaz-Ricart,et al.  The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[39]  Allen R. Chen,et al.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[40]  Kristin S. Jensen,et al.  Endothelium-dependent effects of statins. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[41]  Douglas Losordo,et al.  Statins and the endothelium. , 2007, Vascular pharmacology.